SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-18-222557
Filing Date
2018-07-20
Accepted
2018-07-20 16:18:51
Documents
1
Effectiveness Date
2018-07-20

Document Format Files

Seq Description Document Type Size
1 S-8 POS d562835ds8pos.htm S-8 POS 23298
  Complete submission text file 0001193125-18-222557.txt   24306
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-196740 | Film No.: 18962663
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences